Journal
NEURO-OPHTHALMOLOGY
Volume 41, Issue 6, Pages 326-329Publisher
TAYLOR & FRANCIS AS
DOI: 10.1080/01658107.2017.1316744
Keywords
Androgens; gender reassignment; idiopathic intracranial hypertension; papilloedema testosterone
Categories
Funding
- Association of British Neurologists
- NIHR Clinician Scientist Fellowship [NIHR-CS-011-028]
- Medical Research Council, UK [MR/K015184/1]
- Medical Research Council [G0601430, MR/K015184/1] Funding Source: researchfish
- National Institute for Health Research [NIHR-CS-011-028, ACF-2016-09-005, CL-2009-09-001] Funding Source: researchfish
- MRC [MR/K015184/1, G0601430] Funding Source: UKRI
Ask authors/readers for more resources
Idiopathic intracranial hypertension (IIH), a condition of raised intracranial pressure, is characterised by headaches and visual disturbances. Its pathogenesis is currently unknown; however, dysregulation of androgens may be implicated. Here, the authors present a case of a 22-year-old patient undergoing female-to-male (FTM) gender reassignment who developed IIH shortly after commencing testosterone therapy. This interesting case presents the possibility of androgens having a pathogenic role in IIH.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
